This page includes the latest FDA filings for Abiomed Inc 22 Cherry Hill Dr Danvers Ma 01923 Pma Numberp140003 Supplement Numbers102 Date Received07 20 2022 Decision Date08 18 2022 Product Code Ozd Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
ABIOMED, INC.22 Cherry Hill Dr.danvers, MA 01923 PMA NumberP140003 Supplement NumberS102 Date Received07/20/2022 Decision Date08/18/2022 Product Code OZD Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No | Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella LD | 2022-08-18 |